CKS2 and diffuse large B-cell lymphoma: As illustrated in Figure 2B, the results indicated a significant association between CKS2 overexpression in tumor tissues and poor overall survival (OS) in patients with BL and DLBCL (log‐rank p = 4.8e‐12; log‐rank p = 8.7e‐6).